WADA PROHIBITED Section S2 (2025 Prohibited List) Ipamorelin is explicitly named on the World Anti-Doping Agency (WADA) Prohibited List 2025 under Section S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics as a prohibited growth-hormone secretagogue
Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects
The primary risks include increased hypoglycemia risk (especially with insulin or sulfonylureas), additive gastrointestinal symptoms such as nausea and diarrhea, and unknown effects on medication absorption due to tirzepatide's delayed gastric emptying
Hot flashes are one of the most recognizable symptoms signaling the transition into menopause
CKD evolution In the cohort of CKD patients, no improvement in eGFR after 12 months of treatment, with even a slight decrease in the group of moderate CKD risk, was documented
You might be awake but feel like youre wading through mud
